Zobrazeno 1 - 10
of 38
pro vyhledávání: '"William E Heydorn"'
Autor:
Robert L. Findling, Jianqing Jin, William E. Heydorn, Marcelo M. Gutierrez, Adelaide S. Robb, Karen Dineen Wagner
Publikováno v:
American Journal of Psychiatry. 161:1079-1083
Open-label trials with the selective serotonin reuptake inhibitor citalopram suggest that this agent is effective and safe for the treatment of depressive symptoms in children and adolescents. The current study investigated the efficacy and safety of
Publikováno v:
Depression and Anxiety. 16:121-127
We obtained information on the efficacy and safety of citalopram in settings that resemble actual clinical practice. A total of 1,783 patients participated in this open, uncontrolled, naturalistic Phase IV evaluation of citalopram at 447 U.S. investi
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 9:841-858
Zaleplon (N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethyl acetamide) is a non-benzodiazepine recently introduced for clinical use. This agent is indicated for the short-term treatment of insomnia. Preclinical studies have shown that the
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 8:417-441
Paroxetine is a selective serotonin re-uptake inhibitor (SSRI). In vitro studies show that it is able to produce a concentration-dependent competitive inhibition of serotonin uptake into brain synaptosomes. This effect can also be demonstrated follow
Autor:
Dhanapalan Nagarathnam, Terry W. Schorn, Wai C. Wong, John M. Wetzel, Carlos Forray, Raymond S.L. Chang, William E. Heydorn, George Chiu, Theodore P. Broten, C. Gluchowski, Xingfang Hong, T. A. Branchek, Shou Wu Miao, James Fang, Mohammad R. Marzabadi
Publikováno v:
Journal of Medicinal Chemistry. 41:5320-5333
We report the synthesis and evaluation of novel alpha1a adrenoceptor subtype-selective antagonists. Systematic modification of the lipophilic 4,4-diphenylpiperidinyl moiety of the dihydropyridine derivatives 1 and 2 provided several highly selective
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 6:453-457
The 98th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics was held on March 5-8, 1997. Over 850 researchers and clinicians pre-registered for this meeting. Papers presented at the conference focused on new observation
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 5:597-600
The 97th annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) was held on March 20 – 22, 1996. Lectures, symposia, and poster/slide presentations focused on both new compounds in early clinical development and n
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 4:945-954
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 4:131-137
Autor:
William E Heydorn
Publikováno v:
Expert Opinion on Investigational Drugs. 3:647-651